Associated Papers
The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab.
Shin JW et al.
Biomolecules, 2019
IntOGen-mutations identifies cancer drivers across tumor types.
Gonzalez-Perez A et al.
Nature Methods, 2013
24037244 (PubMed )
Supplement: 41592_2013_BFnmeth2642_MOESM309_ESM.pdf
Select a paper to view details